David Krempa

Chief Business Officer

Chief Business Officer at Eton Pharmaceuticals, Inc., filing insider transactions between 2026-05-22 and 2026-05-27.

Total Purchases

—

0 transactions

Total Sales

$3.2M

5 transactions

Companies Traded

5 total filings

Active Since

2026-05-22

Last: 2026-05-27

Companies

Eton Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-05-27	ETON	Sale	19.7K	$31.47	$619K	25.2K	SEC ↗
2026-05-26	ETON	Sale	37.5K	$31.49	$1.2M	25.2K	SEC ↗
2026-05-22	ETON	Sale	33.0K	$33.22	$1.1M	35.1K